Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
89.60
+1.03 (1.16%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Merit Medical Systems Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,350 | 5,226 | 5,637 | 4,387 | 4,020 | 3,517 | |
Market Cap Growth | 0.28% | -7.29% | 28.50% | 9.13% | 14.28% | 14.07% |
Enterprise Value | 5,721 | 5,655 | 5,933 | 4,681 | 4,255 | 3,804 |
Last Close Price | 89.60 | 88.14 | 96.72 | 75.96 | 70.62 | 62.30 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 36.86 | 40.67 | 46.83 | 46.46 | 53.94 | 72.59 |
Forward PE | 20.55 | 22.51 | 27.13 | 24.04 | 25.97 | 27.70 |
PS Ratio | 3.39 | 3.45 | 4.16 | 3.49 | 3.49 | 3.27 |
PB Ratio | 3.18 | 3.30 | 4.09 | 3.65 | 3.51 | 3.38 |
P/TBV Ratio | 10.13 | 9.68 | 13.50 | 8.88 | 7.90 | 9.80 |
P/FCF Ratio | 26.33 | 24.23 | 30.36 | 39.57 | 58.04 | 29.49 |
P/OCF Ratio | 18.87 | 17.57 | 25.53 | 30.22 | 35.17 | 23.89 |
PEG Ratio | 1.51 | 1.72 | 1.94 | 1.34 | 1.62 | 1.70 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.62 | 3.73 | 4.37 | 3.72 | 3.70 | 3.54 |
EV/EBITDA Ratio | 16.88 | 17.83 | 21.91 | 20.80 | 22.39 | 22.58 |
EV/EBIT Ratio | 26.67 | 29.16 | 35.31 | 34.66 | 39.30 | 45.08 |
EV/FCF Ratio | 28.16 | 26.22 | 31.96 | 42.22 | 61.44 | 31.89 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.49 | 0.52 | 0.58 | 0.74 | 0.24 | 0.30 |
Debt / EBITDA Ratio | 2.30 | 2.46 | 2.78 | 3.72 | 1.32 | 1.72 |
Debt / FCF Ratio | 4.04 | 3.81 | 4.28 | 8.04 | 3.88 | 2.65 |
Net Debt / Equity Ratio | 0.22 | 0.24 | 0.30 | 0.25 | 0.18 | 0.24 |
Net Debt / EBITDA Ratio | 1.10 | 1.18 | 1.54 | 1.35 | 1.11 | 1.48 |
Net Debt / FCF Ratio | 1.83 | 1.74 | 2.25 | 2.73 | 3.04 | 2.09 |
Asset Turnover | 0.58 | 0.59 | 0.57 | 0.63 | 0.70 | 0.65 |
Inventory Turnover | 2.29 | 2.43 | 2.34 | 2.36 | 2.59 | 2.81 |
Quick Ratio | 2.64 | 2.79 | 2.71 | 3.82 | 1.07 | 1.02 |
Current Ratio | 4.20 | 4.34 | 4.27 | 5.45 | 2.40 | 2.04 |
Return on Equity (ROE) | 9.19% | 8.67% | 9.32% | 8.05% | 6.82% | 4.85% |
Return on Assets (ROA) | 4.92% | 4.75% | 4.43% | 4.23% | 4.09% | 3.19% |
Return on Invested Capital (ROIC) | 8.01% | 7.76% | 8.17% | 7.96% | 7.39% | 5.77% |
Return on Capital Employed (ROCE) | 8.30% | 7.90% | 7.60% | 6.40% | 7.50% | 6.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.72% | 2.46% | 2.14% | 2.15% | 1.85% | 1.38% |
FCF Yield | 3.80% | 4.13% | 3.29% | 2.53% | 1.72% | 3.39% |
Buyback Yield / Dilution | 0.86% | -1.85% | -1.73% | -1.19% | -0.54% | -3.47% |